The Company has proposed to subscribe 50.49% of the Equity Share Capital of TLL Parenterals Limited (CIN: U21001GJ2023PLC146963). Further details as per SEBI Regulations and Circulars are attached herewith
The Company has proposed to subscribe 50.49% of the Equity Share Capital of TLL Parenterals Limited (CIN: U21001GJ2023PLC146963). Further details as per SEBI Regulations and Circulars are attached herewith